avisé labs will be attending BioJapan 2026 in Yokohama from October 7–9, 2026. The annual event brings together companies, research institutions and organizations from across the biotechnology, healthcare and life sciences sectors.
For avisé labs, the event provides an opportunity to further expand its international network and explore new collaborations, particularly with hardware-driven MedTech companies.
avisé labs develops custom software, cloud applications and AI-based solutions for healthcare and life sciences. A particular area of interest is the connection between medical hardware and software: sensors, monitoring technologies and other medical devices increasingly generate large amounts of data, creating opportunities for new applications, analytics and AI-supported services.
At BioJapan, avisé labs will therefore focus on establishing relationships with MedTech companies whose expertise lies in medical devices, sensors and other hardware technologies, and where software, data infrastructure or AI could complement existing products and technologies.
We are interested in a range of potential collaboration models, including joint development, technology partnerships, research projects and pilot applications.
BioJapan 2026 will also provide an opportunity to strengthen avisé labs‘ existing international activities in healthcare and life sciences and to identify new opportunities for collaboration between European and Japanese technology companies.
avisé labs looks forward to meeting partners and exploring potential collaborations during the event in Yokohama.